Pearl Steinzor

Molly Mendenhall, BSN, RN, director of quality and compliance at Oncology Hematology Care, Inc (OHC), discussed a 1-year quality improvement project implemented by OHC to standardize comprehensive biomarker testing in patients with non–small cell lung cancer (NSCLC).

Asthma can be predicted using non-biological measurements from the age of 3 years, according to one study.

Mike Brown, vice president of managed services at Cardinal Health, shares how drug cost control software has improved monitoring efficiency and reduced drug spending.

Physicians should be vigilant when managing patients with psoriasis and concurrent metabolic disorders, according to a new study.

An artificial intelligence (AI)-aided stethoscope provides reliable information on asthma exacerbations in children, especially those under 5 years, a study suggests.

Brian Mullen, PhD, head of innovation and product at The Clinic by Cleveland Clinic, discusses how providing second opinions has improved patient and provider experiences in health care.

Bevey Miner, executive vice president of health care strategy and policy, Consensus Cloud Solutions, shares how extraction artificial intelligence is helping train machine learning models to recognize and extract information from documents, providing structured data with confidence scores.

Michael Gieske, MD, director of lung cancer screening at St. Elizabeth Health Care, speaks to the success of the Rural Appalachian Lung Cancer Screening Initiative, along with challenges to implementing increased lung cancer screening.

These findings support the safe use of inhaled corticosteroids (ICS) regarding the risk of pneumonia among children with asthma, according to one study.

Health insurance coverage is a strong determinant of cancer care access and survival, and the observed variations are despite a significant increase in coverage under the Affordable Care Act.

Response rates were greater with deucravacitinib vs placebo or apremilast at 16 weeks in patients with moderate to severe scalp psoriasis, according to one study.

Mike Brown, vice president of managed services at Cardinal Health, discusses how Cardinal Health has worked to integrate key digital health solutions among hospitals across the United States.

David Adamson, MD, founder and CEO of ARC Fertility, discusses how physicians should consider moral and ethical variations of patients when adhering to professional guidelines in fertility care.

Cancer incidence fell by 8.7% across all cancer sites during the first year of the pandemic, according to a new study.

Margaret Liang, MD, MSHPM, gynecologic oncologist and health services researcher and director, Gynecologic Oncology Fellowship Program, Cedars-Sinai Cancer Center, discusses financial toxicity in cancer care and how institutions can help alleviate the financial burden for patients.

Michael Gieske, MD, director of lung cancer screening at St. Elizabeth Health Care, discusses disparities in lung cancer incidence and mortality that the Rural Appalachian Lung Cancer Screening Initiative aims to address.

A topical therapy, PF-07038124 0.01%, administered once daily was more effective than the vehicle control in patients with atopic dermatitis (AD) and plaque psoriasis, a study finds.

Jonathan Silverberg, MD, PhD, MPH, of George Washington University School of Medicine and Health Sciences, explains the benefits of using Janus kinase (JAK) inhibitors to treat patients with atopic dermatitis (AD).

Asthma and allergy drugs such as montelukast and cetirizine were among a list of drugs frequently implicated in major drug-drug interactions.

Gaps exist between self-reported and claims-based estimates of postpartum care among individuals who were covered by Medicaid for their delivery care, according to one study.

Andy Blauvelt, MD, MBA, president of Oregon Medical Research Center, recommends new novel topical therapies over topical steroids for patients with atopic dermatitis (AD).

The top psoriasis articles included topics on new therapies for the treatment of psoriasis in adults.

The most-read rare disease articles include topics on increasing research and awareness on genetic and nongenetic rare diseases.

The most-read articles in digital health covered improved outcomes, patient management, and reduced cost of care in telehealth and app-based care.

Two posters presented at the American College of Allergy, Asthma and Immunology 2023 Annual Scientific Meeting evaluated real-world biologic utilization for patients with severe, uncontrolled asthma.

The most-viewed vaccine content for this year encompassed cost, efficacy, and skepticism surrounding vaccination, particularly targeting COVID-19.

Researchers assessed care and costs incurred by people with asthma, who account for a large share of hospital admissions.

This year’s top 5 most-listened to podcasts included topics on digital health solutions, cardiology, value-based care initiatives, and oncology.

Maternal vaccination during pregnancy may provide important protection before infants are eligible to receive a vaccine, a study suggests.

Most studies involving the treatment of psoriasis do not contain any images of patients, a review finds.